Literature DB >> 6939878

Penicillamine and the SLE syndrome.

J M Walshe.   

Abstract

Penicillamine-induced systemic lupus erythematosus (SLE) and penicillamine-immune complex nephritis are histologically and serologically distinct. One hundred and twenty patients with Wilson's disease treated with penicillamine have been analyzed. Eight developed the serologic changes of SLE; in 4, it was necessary to discontinue treatment. In addition, 6 patients developed immune complex nephritis, which necessitated discontinuing treatment. All but 1 have since been managed on triethylene tetramine 2HCl (Trien).

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6939878

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN： 0380-0903


  11 in total

Review 1.  Drug-induced lupus erythematosus: incidence, management and prevention.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

2.  Sulphasalazine-induced systemic lupus erythematous in a patient with ankylosing spondylitis.

Authors:  W C Tsai; C J Chen; J H Yen; H W Liu
Journal:  Clin Rheumatol       Date:  2002-08       Impact factor: 2.980

3.  Co-occurrence of Wilson's disease and systemic lupus erythematosus: a case report and literature review.

Authors:  Lishan Xu; Bin Liu; Zhaoyang Liu; Ning Tang; Chunhui She; Jing Wang; Bo Zang; Yifei Yang
Journal:  BMC Gastroenterol       Date:  2021-05-21       Impact factor: 3.067

4.  Hudson memorial lecture: Wilson's disease: genetics and biochemistry--their relevance to therapy.

Authors:  J M Walshe
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

5.  Unithiol in Wilson's disease.

Authors:  J M Walshe
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02

Review 6.  Penicillamine in rheumatoid arthritis. A problem of toxicity.

Authors:  H G Taylor; A Samanta
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

7.  Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.

Authors:  R N Hobbs; A L Clayton; R M Bernstein
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

8.  Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance.

Authors:  H M Moutsopoulos; H Giotaki; P J Maddison; A C Mavridis; A A Drosos; F N Skopouli
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

9.  Penicillamine neurotoxicity: an hypothesis.

Authors:  J M Walshe
Journal:  ISRN Neurol       Date:  2011-07-21

10.  ANCA-associated Goodpasture's syndrome in a patient with rheumatoid arthritis on penicillamine.

Authors:  R Sharma; S Jain; V Kher
Journal:  Indian J Nephrol       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.